Current recall status for Systane Original
As of the most recent manufacturer and regulatory updates, there is a voluntary recall affecting specific lots of Systane Original Lubricant Eye Drops due to potential compromised sterility. This status clarifier explains which products are involved, how to check your bottle, and the recommended next steps for patients and caregivers. No nationwide contamination or injury reports have been confirmed, but the recall follows good manufacturing practices to protect ocular health.
Key facts at a glance
| Attribute | Verified Detail | Source Type |
|---|---|---|
| Product | Systane Original Lubricant Eye Drops (ophthalmic solution) | Manufacturer recall notice |
| Recall type | Voluntary, Class II | Regulatory filing |
| Primary reason | Potential sterility compromise; label claim mismatch | Quality control report |
| Affected lot numbers | See manufacturer and FDA listings; varies by bottle size and expiration | Regulatory database |
| Distribution scope | US retail and pharmacy channels | Supply chain record |
| Injury count | None confirmed; precautionary measure | Regulatory update |
| Manufacturer | Bausch Health Companies Inc. | Company announcement |
What triggered the recall
The recall was initiated after internal quality checks indicated a possible breakdown in sterile packaging integrity for certain production lots. Regulatory agencies classify this as a Class II recall, meaning use of the affected product may cause temporary or medically reversible health consequences. The action is precautionary; no adverse events have been substantiated in the field. Ongoing testing determines whether additional lots require inclusion.
Microbial integrity and labeling concerns
Systane Original relies on a multidose formulation that includes preservatives; the recall focuses on sterility assurance rather than preservative efficacy. There is no indication of contamination by pathogens, but deviations in container closure systems or preservative placement can affect the product’s safety profile. Labeling inaccuracies concerning concentration or expiry were also cited in the notice, reinforcing the need for careful lot verification.
How to verify if your bottle is affected
- Check the lot number and expiration date on the bottle base or carton.
- Cross-reference the lot with the recall tables published by the manufacturer and the FDA.
- Contact Bausch Health customer service or your pharmacy if the lot appears listed.
- Do not use the product if it is part of the recalled lot; return or dispose per pharmacy instructions.
What to do if you have recalled drops
If your Systane Original bottle matches an affected lot, stop using it and consult your eye care professional for alternative lubrication options. Discontinue use even if the product appears normal, as sterility cannot be confirmed. Many patients continue their dry eye regimen with unaffected stock or substitute sterile saline rinses until replacement arrives.
Safer alternatives and comparable products
Clinicians and pharmacists can recommend equivalent over-the-counter lubricants with intact supply chains and current sterility validation. Consider preservative-free single-use formats if sensitivity to benzalkonium chloride (BAK) is a concern. The following table summarizes commonly used alternatives and key features.
| Product | Preservative | Viscosity | Unit format | Typical use case |
|---|---|---|---|---|
| Systane Ultra | BAK | Light | Multi-dose | Frequent daytime relief |
| Systane Complete | BAK | Medium | Multi-dose | Mild dryness with lipid support |
| GenTeal Tears | BAK | Light | Multi-dose | Standard lubrication |
| Refresh Plus | BAK | Medium | Multi-dose | Moderate aqueous deficiency |
| Systane Preservative-Free Single Use | None | Tunable | Single-dose | Sensitive or frequent use |
| HypoThermosol PF | None | Light | Single-dose | Contact lens-compatible rinse |
Regulatory and industry context
Voluntary recalls like this one demonstrate compliance with Good Manufacturing Practices (GMP) and close coordination with the FDA’s recall program. Classification as a Class II reflects the absence of serious injury but acknowledges the importance of sterility for ophthalmic products. Manufacturers often issue such actions early when data suggest a deviation, balancing patient safety with continuity of care.
Clinical considerations for eye care providers
For clinicians, the priority is ensuring patients maintain adequate tear film protection without interruption. Preservative-free options reduce the risk of toxicity in high-frequency use, especially for patients with ocular surface disease. When switching units, document the change, verify lot integrity, and counsel on signs of irritation or infection that warrant follow-up.
Long-term takeaways
- Check lot numbers before each use and verify against official recall lists annually.
- Maintain at least one unopened backup supply of lubricants in the home pharmacy.
- Prefer single-use vials for patients with chronic dry eye or those using drops more than four times daily.
- Engage pharmacists and manufacturers for up-to-date recall status when in doubt.
Summary
Systane Original recall notices are precautionary measures centered on sterility and labeling verification, not confirmed safety failures. Patients should confirm lot status, pause use if implicated, and transition to validated alternatives under professional guidance. Consistent lubrication remains essential for ocular surface health, and clinicians can leverage preservative-free formats to mitigate future risk.